Polarean Imaging plc (PLLWF) fair value: what the stock is really worth
As of Sep 25, 2026: fair value of Polarean Imaging plc $0.01, price $0.01, upside -12.1%, quality 41 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.
Watch Polarean Imaging plc for free, get notified when fair value or trend changes. Plus fair value for all 35,000+ stocks, 14 days of Pro free, no card.Watch for freePro now: $1 first month
69 individual criteria per stock, every one traceableSee the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.
How to read this chart
60‑month range $0.0010 – $1.50 · the $0.0066 price screens above the $0.0058 fair value. Green steps = our fair value per fiscal year (point-in-time, no hindsight). Dashed = 300-day average. As of Sep 24, 2026.
Follow Polarean Imaging in your weekly email
Every Wednesday you see whether Polarean Imaging is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform.
Show more
Polarean Imaging plc operates as a drug-device manufacturer and service provider for noble gas hyperpolariser devices in Canada, the United Kingdom, and the United States. The company engages in the research, development, and commercialization of novel imaging solutions with a non-invasive and radiation-free functional imaging platform. It also offers XENOVIEW, a hyperpolarized contrast agent indicated for use with magnetic resonance imaging (MRI) for evaluation of lung ventilation in adults and pediatric patients aged 12 years and older; chest coil; Polarean 9820 Xenon hyperpolarizer that is designed to deliver up to 3 litres of hyperpolarized 129Xe per hour; and Polarean 2881 polarization measurement station, which provides a calibrated measurement of the polarization of hyperpolarized gas within the dose delivery inhalation bag. Polarean Imaging plc was incorporated in 2016 and is based in London, the United Kingdom.
Stock analysis
Polarean Imaging plc (PLLWF) currently trades at $0.0066, while our model-based Fair Value estimate is $0.0058, implying the stock looks roughly 13.8% overvalued today.
Show more
Valuation
How firm this estimate is: it rests on 1 models at a data quality of 91/100, which puts the evidence level at low.
Quality & growth
The Quality Score stands at 41/100 (below-average quality), in the Healthcare sector.
Mixed Growth: Revenue is growing, but margins or cash flow do not fully confirm the trend.
Polarean Imaging plc reported revenue of $3.1M in FY2024 versus $1.1M in FY2020, a compound +30.8%/yr. Reported net income was −$8.5M in FY2024.
Key figures
Market cap $8.0M · P/S ratio 3.11 · Return on equity −81.0% · Return on assets (EBIT) −66.7% · Operating margin −889% · Revenue (TTM) $2.6M · Revenue growth (YoY) −46.9% · Free cash flow −$5.8M.
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 32 out of 100 (low confidence).
What moves the price
The share trades about 40% below its 52-week high and 560% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at 6% fair-value upside, at −12%, PLLWF screens richer than that median.
Fair Value models
Bear $0.0058Fair Value $0.0058Bull $0.0058
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model.Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. If a model's bull case is above four times its base value, the table shows that limit with a > sign (like the overall Bull above): beyond it no assumption holds.Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card.17/100
Revenue is growing, but margins or cash flow do not fully confirm the trend.
Revenue growth 1 year
+246.8%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+37.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+6.1%
Revenue growth 10 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+12.3%
’14
’15
’16
’17
’18
’19
’20
’21
’22
’23
’24
Profit margin (trend) ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.
−261.3% (2019) → −283.2% (2024)
What shareholders gained per year ⓘWe only publish this rate when it is defensible. Reason: fiscal 2024 is a loss year, no rate is defined from a loss
Price, fair value, quality and upside side by side.
Free, no sign-up
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Devices · 357 stocks
Beats the industry median on 2/6 measures
Overall it trails its industry peers.
Valuation
Quality Score41 · Below median
Fair Value upside−12.1% · Above median
Profitability
Return on assets−41.6% · Bottom 25%
Growth and dividend
Revenue growth−46.9% · Bottom 25%
Valuation Multiplesvs Medical Devices median · lower = cheaper
For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.
Is Polarean Imaging plc (PLLWF) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of $0.0058 versus a price of $0.0066, about −12% upside (overvalued).
What is the fair value of PLLWF?
Our model-based fair value for Polarean Imaging plc is $0.0058 (as of Sep 24, 2026), built from audited fundamentals. The current price: $0.0066.
What is the quality score of PLLWF?
Polarean Imaging plc has a Quality Score of 41/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for Polarean Imaging plc (PLLWF)?
Our model-based price target is the fair value of $0.0058 (as of Sep 24, 2026) from 1 valuation models. It is a calculation from audited fundamentals, not an analyst target.
What is the Polarean Imaging plc stock forecast for 2026?
Our models put fair value at $0.0058, about −12% upside versus a price of $0.0066 (overvalued). The calculation is refreshed regularly with new filings.
What is the revenue of Polarean Imaging plc (PLLWF)?
Polarean Imaging plc reported trailing-twelve-month revenue of about $2.6M (latest available figure, as of Sep 24, 2026).
What is the intrinsic value of Polarean Imaging plc (PLLWF)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For Polarean Imaging plc it is $0.0058 per share (as of Sep 24, 2026), against a price of $0.0066. It is the blended result of 1 valuation models (cash flow, earnings, asset, dividend).
Is Polarean Imaging plc stock overvalued or undervalued in 2026?
As of Sep 24, 2026, PLLWF trades above its calculated fair value: price $0.0066, fair value $0.0058, a gap of about −12% (overvalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of PLLWF?
No. The price is what the market pays today ($0.0066); the fair value is what the company's own numbers justify ($0.0058). For Polarean Imaging plc the two are $0.0008 per share apart. That gap is exactly why we show both numbers side by side.
How much is Polarean Imaging plc worth?
The market values Polarean Imaging plc at about $8.0M (market capitalisation, as of Sep 24, 2026). Per share that is $0.0066; our models calculate a fair value of $0.0058 per share.
How solid is the balance sheet of Polarean Imaging plc (PLLWF)?
Balance-sheet figures for Polarean Imaging plc (as of Sep 24, 2026): return on equity −81.0%. They feed the Quality Score of 41/100, which measures business quality independently of the share price.
How far is PLLWF from its 52-week high?
Polarean Imaging plc trades at $0.0066, about 40% below its 52-week high of $0.0110 and 560% above the low of $0.0010 (as of Sep 25, 2026). Distance from the high says nothing about value: that is what the fair value of $0.0058 is for.
Which stocks are comparable to Polarean Imaging plc?
From the same area (Healthcare) we also value Abbott Laboratories,, Medtronic plc, Stryker Corporation, Boston Scientific Corporation, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is Polarean Imaging plc stock attractive at the current price?
The data as of Sep 24, 2026: price $0.0066, calculated fair value $0.0058 (−12%), Quality Score 41/100, from 1 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of PLLWF calculated?
We run Polarean Imaging plc through 1 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of $0.0058, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 16.1 % above its aggregate fair value. Polarean Imaging plc itself currently trades above fair value. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of Polarean Imaging plc (PLLWF)?
The closing price on Sep 25, 2026 was $0.0066. Our model-based fair value is $0.0058, about −12% upside (overvalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with Polarean Imaging plc right now?
The price sits above even our optimistic bull case ($0.0058). The favourable scenario is already priced in. Evidence is limited here (fewer models, shorter history), so the fair value is a rougher estimate than usual.
Key figures of Polarean Imaging plc
How large is the market capitalisation of Polarean Imaging plc (PLLWF)?
The market capitalisation of Polarean Imaging plc is $8.0M. The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of Polarean Imaging plc (PLLWF)?
The price-to-sales ratio of Polarean Imaging plc is 3.11 (last twelve months). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What is the return on equity of Polarean Imaging plc (PLLWF)?
The return on equity (ROE) of Polarean Imaging plc is −81.0% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of Polarean Imaging plc (PLLWF)?
On an EBIT basis the return on assets of Polarean Imaging plc is −66.7% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of Polarean Imaging plc (PLLWF)?
The operating margin of Polarean Imaging plc is −889% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at Polarean Imaging plc (PLLWF)?
Revenue at Polarean Imaging plc is growing −46.9% versus a year earlier (3y avg +37.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How much free cash flow does Polarean Imaging plc (PLLWF) generate?
The free cash flow of Polarean Imaging plc is −$5.8M (fiscal year 2024). The cash truly left after running and investing in the business, this is what pays dividends and buybacks.
How much net cash does Polarean Imaging plc (PLLWF) hold?
Polarean Imaging plc holds more cash than debt, $11.6M net (fiscal year 2024). The company holds more cash than debt, a safety cushion.
Free · no account needed
Watch Polarean Imaging plc in the live analysis
One click puts Polarean Imaging plc on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.
Thin data
Sep 24, 2026